Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 3/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | PDE7A | Q13946 | 7/20 | 0.57 |
| ▸ | PDE7B | Q9NP56 | 5/20 | 0.57 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | KIF18A | Q8NI77 | 1/20 | 0.47 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.46 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29764490 | 1.00 | MAPK1 (0.59) | MAPK1TSHRPDE7APDE7BVCAM1 | |
| SCHEMBL29473418 | 0.83 | MAPK1 (0.64) | MAPK1TSHRPDE7APDE7BVCAM1 | |
| SCHEMBL1511847 | 0.83 | MAPK1 (0.64) | MAPK1TSHRPDE7APDE7BVCAM1 | |
| SCHEMBL1524058 | 0.80 | MAPK1 (0.72) | MAPK1TSHRPDE7APDE7BVCAM1 | |
| SCHEMBL29394047 | 0.78 | MAPK1 (0.69) | MAPK1TSHRPDE7APDE7BVCAM1 | |
| SCHEMBL24508 | 0.78 | S100A4 (0.56) | MAPK1ALDH1A1CYP2D6LMNAKDM4E | |
| SCHEMBL358730 | 0.78 | MAPK1 (0.69) | MAPK1TSHRPDE7APDE7BVCAM1 | |
| SCHEMBL29395434 | 0.78 | S100A4 (0.56) | MAPK1ALDH1A1CYP2D6LMNAKDM4E | |
| SCHEMBL6125034 | 0.78 | MAPK1 (0.63) | MAPK1TSHRPDE7APDE7BVCAM1 | |
| SCHEMBL16491549 | 0.78 | PDE7A (0.52) | MAPK1TSHRPDE7APDE7BVCAM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 516 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113072552-A | Beta-carboline GSK3 beta/DYRK 1A dual inhibitor, preparation method thereof and application thereof in resisting Alzheimer disease | 中国人民解放军北部战区总医院 | 2021-07-06 | — | — | CN | claimed |
| CN-104402920-B | A kind of method for synthesizing the chloroaniline of 2 halo, 3 pinacol borate 5 | 河南科技学院 | 2018-04-03 | — | — | CN | claimed |
| CN-104402920-A | Method for synthesizing 2-halogenated-3-pinacol borate-5-chloroaniline | XUE FENG | 2015-03-11 | — | — | CN | claimed |
| WO-2015022282-A1 | NITROGEN-DOPED CARBON NANOTUBES AS HIGH SELECTIVE NOBLE METAL-FREE CATALYSTS FOR HYDROGENATION OF FUNCTIONALIZED NITROAROMATICS | BAYER CROPSCIENCE AG (DE) | 2015-02-19 | — | — | WO | claimed |
| EP-2837612-A1 | Nitrogen-doped carbon nanotubes as high selective noble metal-free catalysts for hydrogenation of functionalized nitroaromatics | Bayer Technology Services GmbH (DE) | 2015-02-18 | — | — | EP | claimed |
| EP-3749325-B1 | DREADD ACTUATORS | US HEALTH (US) | 2026-04-08 | — | — | EP | disclosed |
| US-20260085067-A1 | CYCLIC SULFONAMIDE RIBONUCLEOTIDE REDUCTASE (RNR) INHIBITORS AND USES THEREOF | BOUNDLESS BIO INC (US) | 2026-03-26 | — | — | US | disclosed |
| US-12588407-B2 | Organic light-emitting element | LG CHEM, LTD. (KR) | 2026-03-24 | — | — | US | disclosed |
| EP-4676922-A1 | BIFUNCTIONAL COMPOUNDS CAPABLE OF DEGRADING ANDROGEN RECEPTORS | Astrazeneca AB (SE) | 2026-01-14 | — | — | EP | disclosed |
| US-12495718-B2 | Compound and organic light emitting device comprising same | LG CHEM, LTD. (KR) | 2025-12-09 | — | — | US | disclosed |
| US-12419191-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2025-09-16 | — | — | US | disclosed |
| EP-4587437-A1 | CYCLIC SULFONAMIDE RIBONUCLEOTIDE REDUCTASE (RNR) INHIBITORS AND USES THEREOF | Boundless Bio, Inc. (US) | 2025-07-23 | — | — | EP | disclosed |
| CN-1114506-A | Heterobicyclic sulfonamide derivatives and sulfonate derivatives | EISAI CO LTD (JP) | 1996-01-03 | — | — | CN | disclosed |
| EP-0673937-A1 | BICYCLIC HETEROCYCLIC SULFONAMIDE AND SULFONIC ESTER DERIVATIVES | Eisai Co., Ltd. (JP) | 1995-09-27 | — | — | EP | disclosed |
| EP-0493030-A1 | Preparation of difluorobenzenes | RHONE-POULENC CHEMICALS LIMITED (GB) | 1992-07-01 | — | — | EP | disclosed |
| EP-0017455-B1 | LINEAR CRYSTALLINE ALPHA-ALKYLPOLYBENZYLS AND PROCESS FOR PREPARING THEM | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1983-04-13 | — | — | EP | disclosed |
| US-4259475-A | FRIEDEL-CRAFTS COMPLEX CATALYST | EXXON RESEARCH & ENGINEERING CO. (US) | 1981-03-31 | — | — | US | disclosed |
| EP-0017455-A1 | Linear crystalline alpha-alkylpolybenzyls and process for preparing them | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1980-10-15 | — | — | EP | disclosed |
| US-4191760-A | ANTISCHIZOPHRENICS | ABBOTT LABORATORIES (US) | 1980-03-04 | — | — | US | disclosed |
| US-4096261-A | ANTISCHIZOPHRENICS | ABBOTT LABORATORIES (US) | 1978-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12419191-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | PIEZO1, OR51E2, OR10J3 | MAPK1 493/4885TSHR 4607/4885PDE7A 4819/4885 |
| US-12495718-B2 | Compound and organic light emitting device comprising same | RNF10, UGT1A10, LAS1L | MAPK1 1917/4885TSHR 2721/4885PDE7A 4882/4885 |
| US-20260085067-A1 | CYCLIC SULFONAMIDE RIBONUCLEOTIDE REDUCTASE (RNR) INHIBITORS AND USES THEREOF | RRM1, RRM2B, RRM2 | MAPK1 3269/4885TSHR 76/4885PDE7A 2837/4885 |
| US-12588407-B2 | Organic light-emitting element | LAS1L, LEF1, ARL1 | MAPK1 710/4885TSHR 1995/4885PDE7A 4865/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.